141080.KQ
Strong SellSinkerLigaChem Biosciences Inc. · Healthcare · South Korea · $2.7B · Avg Vol: $13M/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
3
StockRankGet insider-trade alerts
QualityQuality
33
ValueValue
23
MomentumMomentum
10
P/E (TTM)
—
peers 16.4x
ROE
-36.5%
peers 0.3%
D/E
0.0x
peers 0.3x
Dividend %
—
trailing yield
Director trades · 180d
+$1.1M · −$225.9K →
bought · sold by directors
Subst. holders: +$73.5M · −$3.4M
Buybacks · 180d
None →
ABOUT LIGACHEM BIOSCIENCES INC.
Read
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
FINANCIAL SUMMARY (KRW)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.4B | 34.1B | 125.9B | 141.6B | 61.8% | 96.6B | 284.0B | 287.5B | 42.5% |
| EPS (KRW) | -1,609 | -2,595 | 227.00 | -2,042 | — | -1,997 | — | — | — |
| Shares | 25.5M | 28.0M | 36.3M | 36.4M | +42.9% | 36.4M | — | — | — |
| Debt | 12.2B | 12.6B | 819.9M | 2.7B | -39.2% | 2.5B | — | — | — |
| Equity | 219.6B | 148.2B | 616.0B | 507.6B | 32.2% | — | — | — | — |
| Op CF | -7.1B | -62.2B | 78.5B | -124.5B | — | -187.4B | — | — | — |
| Inv CF | -16.2B | 9.4B | -457.4B | 94.1B | — | — | — | — | — |
| Fin CF | 3.2B | -1.9B | 443.4B | -628.8M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-30.8%
SMA 50SMA 200
Close
$59.61
RSI (14)
31.2
52W High
$165.99
From 52W High
0.4%
SCORE BREAKDOWN
Quality
33
ROIC
-14.5%32.0
ROE
-36.5%23.2
GP/Assets
13.5%32.0
Op. Margin
-1300.9%6.2
FCF/Assets
-18.6%22.0
Piotroski
316.0
Int. Cover
-50.0x5.9
D/E Ratio
0.01x88.1
Current Ratio
9.37x86.6
Value
23
P/E (TTM)
—N/A
EV/EBITDA
-13.5x25.0
P/FCF
—N/A
P/B
6.0x22.3
P/S
30.3x11.8
Div Yield
—N/A
Momentum
10
52W High %
36%11.2
RS 6M
-81%2.7
SMA 50/200
0.63x5.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$2.7B
P/E (Forward)
1053.8x
Gross Margin
87.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 141080.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 141080.KQ | LigaChem Biosciences Inc.(you) | $2.7B | 3 | Strong Sell |
| 310210.KQ | Voronoi, Inc. | $2.3B | 1 | Strong Sell |
| 298380.KQ | ABL Bio Inc. | $3.1B | 1 | Strong Sell |
| 028300.KQ | HLB Co., Ltd. | $3.5B | 1 | Strong Sell |
| 347850.KQ | D&D Pharmatech Inc. | $1.8B | 1 | Strong Sell |
| 226950.KQ | OliX Pharmaceuticals, Inc | $1.6B | 3 | Strong Sell |
| 302440.KS | SK bioscience Co.,Ltd. | $2.2B | 14 | Strong Sell |
| 0126Z0.KS | Samsung Epis Holdings Co., Ltd. | $6.8B | 5 | Strong Sell |
| 475830.KQ | Orum Therapeutics, Inc. | $1.0B | 1 | Strong Sell |
| 127120.KQ | JS Link, Inc. | $854M | 9 | Strong Sell |
Peer medians: ROE 0.3% · P/E 16.4x · Gross margin 42.8%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.